Skip to main content

Table 3 Cumulative cost effectiveness/savings after 5, 10, 25, and 50 years of vaccination program. Cost savings is achieved within 6 years considering indirect costs and within 8 years if indirect costs are excluded. Values are for the entire population

From: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach

Cumulative outcomes Universal Vaccination
5 y 10 y 25 y 50 y
QALY’s Gaineda 4800 10,521 24,144 37,502
Vaccination Cost (millions) $9.40 $17.52 $35.76 $52.83
Disease Cost Avoided (millions) $8.06 $18.60 $47.78 $81.41
Indirect cost avoided (millions) $0.99 $2.61 $8.00 $14.03
Total Cost Savings(millions, including indirect costs) $3.69 $20.03 $42.60
Total Cost Savings(millions, excluding indirect cost) $1.09 $12.02 $28.57
ICERb ($/QALY, including indirect costs) 75 Cost saving Cost saving Cost saving
ICER ($/QALY, excluding indirect cost) 281 Cost saving Cost saving Cost saving
  1. aQALY, quality-adjusted life-year
  2. bICER, incremental cost-effectiveness ratio